Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-11-000035)

Filing Details

Accession Number:: 0000711377-11-000035
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-03 17:50:24
Reporting Period:: 2011-09-29

Filing Date:: 2011-10-03
Accepted Time:: 2011-10-03 17:50:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517426	J. Steven Quinlan	620 Lesher Place Lansing MI 48912	Vice President & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-29	147	$34.38	647	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to Buy)	Acquisiton	2011-09-29	5,000	$0.00	5,000	$34.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000		2016-09-29	No	4	A	Direct

Footnotes

Shares acquired are held in the Neogen Corporation 401(k) Plan
The options were granted September 29, 2011 and vest 20% yearly through September 29, 2016